Failure Analysis Market

The failure analysis market is estimated to be valued at USD 3.9 billion in 2020 and is projected to reach USD 5.9 billion by 2025; it is expected to grow at a CAGR of 8.3% from 2020 to 2025. A few key factors driving the growth of this market include imposition of safety rules & regulations by governments and international bodies, rise in demand for failure analysis from the electronics & semiconductor industry, technological advancements in microscopes, and rising focus on nanotechnology and regenerative medicine.

Failure Analysis companies include:

• Thermo Fisher Scientific, Inc. (US),
• Hitachi High-Technologies Corporation (Japan),
• Carl Zeiss (Germany),
• JOEL, Ltd. (Japan),
• TESCAN OSRAY HOLDING (Czech Republic),
• Bruker (US),  
• Semilab (Hungary),
• A&D Company, Ltd. (Japan),
• HORIBA, Ltd. (Japan),
• Leica Microsystems GmbH (Germany),
• Veeco Instruments (US),
• Oxford Instruments (UK), and
• Eurofins Scientific (Luxembourg).

To know about the assumptions considered for the study download the pdf brochure

Hitachi High-Technologies Corporation (Japan) develops, manufactures, markets, and provides service support to electronic and electrical equipment and systems. It manufactures electron microscopes, FIB systems, and atomic force microscopes under the Nano-Technology Solutions segment. Products under this segment are used for inspection and failure analysis. Hitachi High-Technologies Corporation is among the key players in the failure analysis market, due to its continuous focus on electronic device systems as well as science & medical systems. The company has focused on technology development to spur business expansion in the failure analysis equipment industry. Major investments in the semiconductor industry across the Asia Pacific region will drive the revenue growth for the Hitachi High-Tech Group. In 2018 and 2019, the company has also launched new products, such as series CG7300, CV6300, and NX9000 FIB/FIB-SEM system, to be used in industrial applications. Its focus on biotechnology & healthcare, as well as advanced industrial systems, is expected to boost the revenue, thereby increasing its share in the failure analysis market in the US and Europe

Thermo Fisher Scientific, Inc. (US) focuses on designing, manufacturing, and supplying analytical instruments, laboratory equipment, diagnostic products, software, and services for research, clinical, and industrial applications. Thermo Fisher Scientific’s microscopes business unit falls under a prominent subsidiary named FEI Company, which operates under Thermo Fisher’s Analytical Instruments business segment. Thermo Fisher offers electron microscopes, ion-beam microscopes, FTIR-Raman microscopes, accessories, and software. The firm’s versatile, high-performance scanning electron microscopes are used for the characterization of a broad range of materials, including nanoparticles, metals, and composites & coatings. The company focuses on the expansion of its system business, to date, more than 2,000 Thermo Scientific systems installed across the globe. The company uses organic and inorganic growth strategies to strengthen its FIB market position. It launched multiple scanning and transmission electron microscopes, including Spectra 300 S/TEM, Krios Cryo-TEM electron microscope, Phenom Desktop SEM, Prisma E SEM, Verios G4, and Aquilos Cryo-FIB.

Related Reports:

Failure Analysis Market by Equipment (Optical Microscope, SEM, TEM, FIB, Scanning Probe Microscope, Dual Beam), Technology (SIMS, EDX, CMP, FIB, BIM, RIE), Application, & Geography - Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]